Exelixis
EXEL
#2236
Rank
$6.44 B
Marketcap
$22.12
Share price
0.89%
Change (1 day)
17.47%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company